Unlocked Labs Inc.
Laramie, WY
- UEI
- HE5AH1LKAUA3
- CAGE
- 8DN78
- Primary NAICS
- Not on record
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 1482 Commerce Dr u, Laramie, WY 82070, USA
- Website
- unlocked-labs.com
- Founded
- 2018
- Employees
- 1-10
- Estimated annual revenue
- $0-$1M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant awards
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Fzata Inc. | Halethorpe, MD | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
| Resvita Bio Inc. | Emeryville, CA | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
| Siolta Therapeutics Inc. | San Carlos, CA | 325412 Pharmaceutical Preparation Manufacturing |
| Osel, Inc. | Mountain View, CA | 325412 Pharmaceutical Preparation Manufacturing |
| Medosome Biotec LLC | Bloomington, IN | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
About the company
Unlocked Labs Inc. is a for-profit corporate entity registered in SAM.gov since August 2019, with a registration valid through March 15, 2025. The company appears to specialize in biotechnology research focused on developing innovative probiotic solutions for medical conditions, particularly targeting metabolic and urological disorders. Their core business model centers on engineering microorganisms to address specific health challenges through advanced bacterial and yeast strain development.
The company has successfully secured multiple federal grants from civilian agencies, primarily the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and the National Science Foundation (NSF). Their recent grant work has concentrated on developing specialized probiotic interventions, including a Bacillus subtilis strain engineered to biodegrade oxalate for kidney stone prevention (R44DK133067 and R43DK133067) and a probiotic yeast treatment for hyperuricemia and gout (NSF grant 2014679). These projects demonstrate a sophisticated approach to medical biotechnology, focusing on creating microbiological solutions that can potentially mitigate complex medical conditions by targeting underlying metabolic processes. The grants, which are structured as Small Business Innovation Research (SBIR) Phase I and Phase II awards, suggest Unlocked Labs Inc. is actively developing translational research with potential commercial applications in therapeutic microbial interventions.
Quick answers
Is Unlocked Labs Inc. registered in SAM.gov?
Yes. Unlocked Labs Inc.'s SAM.gov registration is active through January 16, 2027.
What is Unlocked Labs Inc.'s most recent federal award?
Unlocked Labs Inc.'s most recent federal grant award is Oxalate biodegrading probiotic for kidney stone prevention (R44DK133067), from National Institute of Diabetes and Digestive and Kidney Diseases (NIH), on March 1, 2023.
On GovTribe
See Unlocked Labs Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors